Status:
COMPLETED
Evaluation of the Omnipod DASH in Children and Adolescents With Type 1 Diabetes Mellitus
Lead Sponsor:
Jessa Hospital
Conditions:
Diabetes Mellitus, Type 1
Children
Eligibility:
All Genders
6-18 years
Brief Summary
In this study the usability of the Omnipod DASH insulin administration system is evaluated prospectively by two questionnaires. The effect on the metabolic control is evaluated retrospectively by anal...
Detailed Description
In the study the usability of the Omnipod DASH (= insulin patch pump) is evaluated prospectively by two questionnaires. The first questionnaire concerns practical items on the application of the pump ...
Eligibility Criteria
Inclusion
- Children and adolescents with type 1 diabetes mellitus
- Patients who started in 2021 with the Omnipod DASH insulin administration system in the Jessa Hospital
Exclusion
- Children and adolescents without type 1 diabetes mellitus
- Children and adolescents with type 1 diabetes treated with insulin pens or other insulin pumps
Key Trial Info
Start Date :
April 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05377385
Start Date
April 13 2022
End Date
September 1 2022
Last Update
September 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Limburg, Belgium, B3500